Sachin Bhagwat, PhD

Chief Scientific Officer
Wockhardt Limited, India

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-1209) Efficacy of β-lactam Enhancer Based Zidebactam-Cefepime Combination (WCK 5222) versus Meropenem in Adults with Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) in a Global, Randomized, Double-blind, Phase 3 Trial
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET